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12. PRURITUS AND QUALITY OF LIFE
Elke Weisshaar, Thomas L. Diepgen
Department of Social Medicine, Occupational and Environmental Dermatology, University of
Heidelberg, Germany
Objectives: Itching is the most frequently described symptom in dermatology. As it is a
subjective symptom that cannot be verified by physical or biophysical examination, the pa-
tient’s evaluation including past medical history, personal factors of life style, psychological
factors and measurement of its severity is a challenge. The clinician attempting to identify the
underlying causes of pruritus and trying to treat the patient appropriately frequently faces
difficulties in achieving all these demands in a practicable way.
Methods: For this purpose, a questionnaire is very helpful, especially in those patients who
suffer from severe pruritus as the main and leading symptom. The questions ought to concern
frequency, localisation, duration and quality of itching and scratching. The patients should
also be asked about their idea of hypothesized causes. Past medical history, personal life
style factors, co-diseases, drug consumption and previous therapeutical regimens of their
itching should be included. Additionally, patients should be questioned for associated symp-
toms such as e.g. sleeplessness, nervousness, uneasiness, sweating, indigestion. Finally, it is
important to ask for their self-evaluation and personal opinion concerning quality of life.
Results: We present data about 132 patients (59 men, 73 women) aged 14 to 84 years who
completed a special questionnaire for pruritus patients. 56.8% (group 1) suffered from pru-
ritus due to a primary dermatological aetiology (e.g. eczema, prurigo, lymphoma), in 35.6%
(group 2), it was a symptom of an underlying systemic disease (e.g. renal, hepatic, neoplastic
pruritus) and in 7.6% (group 3) pruritus was of unkown origin. Differences in frequency,
quality, circadian rhythm of itching and scratching were found. The quality of life including
mood and emotional status is more affected in group 1. Additionally, we applied the English
version of this questionnaire to 84 African dermatology patients in Uganda.
Conclusions: This questionnaire helps to obtain important information about pruritus pa-
tients in a purposeful time-frame and facilitates the identification of possible causes and the
best individual therapy for pruritus. Besides, the physician obtains insights into the patient’s
mental health and quality of life.
13. ADVERSE REACTIONS TO INJECTABLE FILLER SUBSTANCES IN AESTHETIC DER-
MATOLOGY – RESULTS OF THE INJECTABLE FILLER SAFETY-STUDY (IFS-STUDY)
Linn Wo¨lber, Hendrik Zielke, Luitgard Wiest, Berthold Rzany
division of Evidence Based Medicine (dEBM), Klinik fu¨r Dermatologie, Charite´ – Berlin –
Germany; Praxis fu¨r Dermatologie – Mu¨nchen – Germany Germany
Objectives: To describe adverse reactions in patients treated with injectable filler sub-
stances and to develop hypothesis on risk factors prior to further studies on the safety of
these medical devices.
Methods: With help of the Berlin Medical Association all local dermatologists, plastic sur-
geons as well as oral surgeons were identified, contacted and asked to report possible
adverse reactions that occurred between 2000 and 2003. Additional cases were obtained
from a private practice from Munich. All reported patients were interviewed by a question-
naire and additional documentation (photographs) was obtained, whenever possible. Adverse
reactions were evaluated by patient as well as area treated. All data was analyzed by de-
scriptive measures.
Results: 57 patients (1 male, 56 female, age 47  11 (sd) years) treated with 13 different
filler materials could be found. 42 patients were treated with only one filler, 15 with 2 and more
fillers. From the 15 patients treated with 2 and more fillers, 7 patients were defined as being
treated with only one filler as the other fillers in these patients were injected in areas where no
adverse reaction developed. From the patients treated with only one filler (by this definition)
22 were injected with a temporary and 23 with a permanent filler. In the 42 patients treated
with only one filler all together 213 areas were treated. In 142 (66,7%) areas adverse reactions
occurred. Time until appearance was 13,1  15,9 (sd) months after injection. As adverse
events continuing pain, swelling, nodules, pigmentation and erythema were found. For four
different substance classes (HEMA and hyaluronic acid n¼12, PLA n¼11, collagen n¼9,
PMMA and collagen n¼ 6) characteristic side effect profiles could be described.
None of these patients had been reported to the German Federal Institute for Drugs and
Medical Devices (BfArM) before.
Conclusions: The existing adverse event reporting system is able to identify only a limited
number of cases. With a partially population based registry the IFS-study did provide the
largest number so far of patients with adverse reactions to injectable fillers. The results
support the continuation of the Berlin registry to gain further insight in theses sometimes
extremely disfiguring adverse reactions.
14. IS ATOPY A PROTECTIVE OR RISK FACTOR FOR CANCER? A REVIEW OF EPIDE-
MIOLOGICAL STUDIES
H. Wang, T.L. Diepgen
Department of clinic Social Medicine, University of Heidelberg
Objective: Evidence of a link between a history of atopy and cancer risk has been accu-
mulating over the past few decades. The purpose of this paper is to review the recently
published epidemiological studies on the association between atopy and the risk of cancers.
Methods: Through a MEDLINE electronic search (January 1986 to April 2004) with an ad-
ditional review of cited references, we identified studies with quantitative data on the relation
of atopy (irrespective of its definition or subtype) to cancer.
Results: A total of 63 articles were reviewed, including 52 case-control studies and 11
cohort studies. The protective effect of atopy in colorectal cancer has been observed con-
sistently in the case-control studies, but not in cohort studies. A consistent inverse asso-
ciation between self-reported atopy and glioma risk has been shown, but there is absence of
such an association for meningioma. In most studies, the risk of leukaemia, in particular
childhood leukaemia, tends to be lower among people with a history of atopy. Studies which
looked at the association between atopic disease and risk of cancers of pancreatic, breast,
lymphoma showed varying outcomes. Most studies on the atopy-pancreatic cancer relation
suggested an inverse association. For lymphoma, most studies have shown no substantial
association. Overall evidence indicates an increased risk of lung cancer among persons with
a history of atopy.
Conclusion: Despite the mixed results, the emerging picture from most of the currently
available epidemiologic data indicate that atopic disease is associated with a reduced risk for
cancer. Further research should focus on a more carefully documented ‘‘atopy’’ status, to
advance our understanding of role that allergies can play in the risk of developing cancer.
15. SCREENING FOR SKIN CANCER IN AN ADULT WORKING POPULATION
H. Wang, M. Radulescu, M. Bock, E. Weisshaar, T. Bruckner, T. L. Diepgen
Department of clinic social Medicine, University of Heidelberg, Germany
Objectives: Melanoma and non melanoma skin cancer (NMSC) are now the most common
types of cancer in the white populations and increasing incidence rates for skin cancer has
been a major public health concern. However, the benefit of skin cancer screening is still
controversial. The aims of this study were 1) To enhance awareness and early detection of
non-melanoma and melanoma skin cancer in a population of factory employees; 2) To identify
the proportion of the employees who have an increased risk of developing skin cancer.
Methods: In combination with a short questionnaire we offered on-site free skin examina-
tions to the employees of five large companies in Germany. We recorded the demographics,
skin cancer risk factors (changing mole, skin-type, family history, size of congnital naevus)
and presumptive cancer or cancer-related diagnoses (actinic keratosis (AK), basal cell
carcinoma (BCC), squamous cell carcinoma(SCC), dysplastic nevus (DN), and melanoma).
Results: In total, we screened 14,553 subjects(10,715 males and 3838 females) with mean
age of 40 years, during a series of consecutive sessions. A presumptive diagnosis related to
skin cancer was detected in 782 (5%), including 72 (0.5 %) with presumptive AK, 52 (0.4 %)
with BCC, 2 (0.01%) with SCC, 634 (4%) with DN, and 22 (0.2%) with possible melanoma. In
all, 33% of those examined had at least one risk factor and 8% had at least two risk factors:
13% reported a changing mole, and 22% had skin type I or II.
Conclusions: As expected, rates of suspected melanoma and NMSC in the screening was
low in this relatively young population. About one third of the screenees who had increased
risk for developing skin cancer will benefit from the screening. In the cost-benefit analysis of a
factory-based health promotion campaign, increased skin cancer awareness should be taken
into account for the rationale to offer such screening programs. We concluded that this skin
cancer screening campaign fulfilled the basic principles of screening for diseases.
16. EFFICACY OF INTERVENTION TO INCREASE THOROUGH SKIN SELF-EXAMINATION
AND EFFECT ON SURGERY ON THE SKIN: RESULTS OF THE CHECK-IT-OUT PROJECT
MA Weinstock, PM Risica, RA Martin, KJ Smith, W Rakowski, M Berwick, MG Goldstein, T
Lasater
VAMC, RI Hosp & Brown Univ, Providence, RI
Monthly thorough skin self-examination (TSSE) is increasingly recommended for early de-
tection of melanoma, and it may be effective in reducing melanoma mortality. However, it has
been the focus of relatively little research given the associated publicity. We report results of
the Check-It-Out Project, a randomized trial of an intervention designed to encourage
monthly TSSE.
The intervention included a 14-minute video, cues, aids, a tailored follow-up letter, and
other material that encouraged TSSE. The control intervention focused on a healthy diet.
Participants were recruited at routine visits to their primary care clinician and were inter-
viewed by telephone before randomization and at 2, 6, and 12 months after. Of the 1356
participants, 80%, 75%, and 66% completed the 2-, 6-, and 12-month interviews. The two
groups had similar proportions of completed interviews at each time point, and no differences
in baseline characteristics.
The proportion who reported performing TSSE (within the prior 2 months) in the skin and
diet groups were 18% and 17% at baseline (p¼ .7), but there was a marked difference at 2
months (53% and 31%, po.0001), which persisted at 6 and 12 months (55% and 35% at
both time points, po.0001). Similarly, of the 7 areas of the body investigated specifically, the
skin and diet groups examined a mean of 2.6 and 2.5 at baseline (p¼ .4), but at 2, 6, and 12
months they examined 5.3 vs. 3.9, 5.2 vs. 4.0, and 5.1 vs. 3.8 areas (all po.0001). We also
asked ‘‘Did the doctor or nurse biopsy, freeze, or cut the skin’’? Medical records were sought
to verify all affirmative responses. During the 6 months prior to randomization, at least one
surgical procedure on the skin was verified in 6.5% of the skin group and 6.0% of the diet
group (p¼ .7). From randomization to 2 months, those numbers were 4.0% and 2.4%
(p¼ .14). From 2 to 6 months, they were 6.1% and 1.8% (p¼ .0006), and from 6 to 12 months,
6.3% and 4.8% (p¼ .3).
We observed a substantial effect of our intervention on performance of TSSE, and this was
associated with a substantial increase in surgical procedures performed on the skin, although
by 6 to 12 months after intervention that increase had diminished despite a sustained effect
on performance of TSSE. This may mean that a campaign can be crafted to increase early
detection of melanoma in the long-term through TSSE without causing a long-term increase
in morbidity and cost associated with surgical procedures on the skin.
17. UNITED AGAINST SKIN CANCER
Leigh Martin, Michele Martinelli
Centro Studi GISED, Bergamo, Italy
Concern over the increasing incidence of melanoma and non-melanoma skin cancers have
prompted substantial funds be put towards public cancer education since the 1980s.
Countries like Australia and America have well-established campaigns and have been
investing in this field for well over 20 years. But campaigns on prevention or early detection
have been going on across all continents. Projects which commenced as small community
efforts in South America 10 years ago have gradually become formal year-round pro-
grammes. European countries are at varying stages of campaign development, the United
Kingdom and Italy manage now to reach most members of the public regularly. In Africa no
established prevention programmes exist (albinos (1:2000–5000 people) are at high risk)
whereas South Africa has a more structured approach in its public education efforts, related
to that of Australia.
The successes, problems and future of adopted solar protection policies and practices
across these continents will be presented in association with preliminary findings from the
systematic review currently underway, ‘‘educational programmes for skin cancer prevention’’,
which evaluates the effectiveness of different methods of public skin cancer education in
different population settings, from beachgoers to school children to outdoor workers.
ABSTRACTS 855125 : 4 OCTOBER 2005
